Two-stage hepatectomy for multiple bilobular liver metastases from colorectal cancer

Hepato-Gastroenterology

Volumn 52, Issue 63, 2005, Pages 913-919

  Togo, Shinji ^a,b   Nagano, Yasuhiko ^a   Masui, Hidenobu ^a   Tanaka, Kuniya ^a   Miura, Yasuhiko ^a   Morioka, Daisuke ^a   Endo, Itaru ^a   Sekido, Hitoshi ^a   Ike, Hideyuki ^a   Shimada, Hiroshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Colorectal cancer; Multiple liver metastasis; Two stage hepatectomy

Indexed keywords

CISPLATIN; DOXIFLURIDINE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; UFT;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; EVALUATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEPATITIS; HOSPITAL DISCHARGE; HUMAN; LASER COAGULATION; LIVER FAILURE; LIVER METASTASIS; LIVER REGENERATION; LIVER RESECTION; LUNG METASTASIS; MALE; MICROWAVE THERAPY; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; SUBPHRENIC ABSCESS; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL RATE; TWO STAGE HEPATECTOMY; VOLUMETRY;

AGED; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; PROGNOSIS; REOPERATION; RISK ASSESSMENT; SURVIVAL RATE;

EID: 20644445671     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H: Two-stage hepatectomy: Planned strategy to treat irresectable liver tumors. Ann Surg 2000; 232:777-785.
2. Tanaka K, Shimada H, Togo S, Ota M, Yamaguchi S, Ike H: Is hepatic resection for multiple liver metastases from colorectal carcinoma acceptable treatment? Hepatogastroenterology 2001; 48:803-807.
3. Fujii Y, Shimada H, Endo I, Kamiyama M, Kamimukai N, Tanaka K, et al: Changes in clinicopathological findings after portal vein embolization. Hepatogastroenterology 2000; 47:1560-1563.
4. Yamanaka N, Okamoto E, Kuwata K, Tanaka N: A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg 1984; 200:658-663.
5. Iwatsuki S, Esquivel CO, Gordon RD, Starzl TE: Liver resection for metastatic colorectal cancer. Surgery 1986; 100:804-810.
6. Sugihara K, Hojo K, Moriya Y, Yamasaki S, Kosuge T, Takayama T: Pattern of recurrence after hepatic resection for colorectal metastases. Br J Surg 1993; 80:1032-1035.
7. Takahashi K, Mori T, Yasuno M: Treatment for hepatic metastases from colorectal cancer. J Jap Coll Surg 1997; 22:229-236. (In Japanese)
8. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, et al: Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224:509-522.
9. Lygidakis NJ, Vlachos L, Raptis S, Rassidakis G, Balaskas C, Sgourakis G, et al: New frontiers in liver surgery. Two-stage liver surgery for the management of advanced metastatic liver disease. Hepatogastroenterology 1999; 46:2216-2228.
10. Wagner JS, Adson MA, Van Heerden JA, Adson MH, Ilstrup DM: The natural history of hepatic metastases from colorectal cancer. Ann Surg 1984; 199:502-506.
11. Murray KD: Excision of pulmonary metastasis of colorectal cancer. Semin Surg Oncol 1991; 7:157-161.
12. Regnard JF, Grunenwald D, Spaggiari L, Girard P, Elias D, Ducreux M, et al: Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. Ann Thorac Surg 1998; 66:214-219.